MedTrace Logo

Flaxseed Intervention on Metabolic Syndrome

NCT00733772 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 189

Last updated 2015-02-05

No results posted yet for this study

Summary

The purpose of this study is to determine whether daily supplement of 30 grams flaxseed is effective in the treatment of metabolic syndrome (MetS).

Conditions

  • Metabolic Syndrome X

Interventions

DIETARY_SUPPLEMENT

flaxseed

30 grams/day of flaxseed for 12 weeks

BEHAVIORAL

Health lifestyle counseling

Health lifestyle counseling accroding to AHA reccommendation

Sponsors & Collaborators

  • Chinese Academy of Sciences

    lead OTHER_GOV

Principal Investigators

  • Xu Lin, MD, PhD · Institute for Nutritional Sciences, Chinese Academy of Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-03-31
Primary Completion
2009-07-31
Completion
2009-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00733772 on ClinicalTrials.gov